328697
Chronic cumulative exposure – categorizing residence in geothermal area and cancer incidence
Methods: The census cohort was followed from 1981 to 2014. The outcome was obtained from nation-wide cancer, death, and out-migration registries by record linkage of personal identifier. The accumulation of residence experience was obtained by record linkage with national rosters through the study period. The study group was compared with reference population according to continuous and categorized exposure metrics, and in internal analysis using Cox regression modeling adjusting for age, gender, education, housing, reproductive factors and smoking habits with different induction periods.
Results: The HR for all cancers was 1.18 (95%CI 0.97-1.43) for 1-5 years residence, 1.22 (95%CI 1.04-1.43) for 10-15 years residence, and 1.29 (95%CI 1.11-1.49) for 20-24 years residence as compared with reference area. The HR for internal analysis with five years lag for all cancers was for residence of 1 year (reference), 5 years 1.30 (95%CI 0.93-1.80), 10 years 1.68 (95%CI 1.11-2.54), 15 years 2.28 (95%CI 1.38-3.75), 20 years 2.57 (95%CI 1.47-4.50), and 24 years 4.45 (95%CI 2.85-6.96).
Conclusion: Immortal person-time is excluded from the comparison of exposed and unexposed to avoid bias. Different lag and follow-up time is important for the internal analysis.
Learning Areas:
EpidemiologyLearning Objectives:
Explain the procedure of register based cohort studies
Discuss the use of residence as surrogate of exposure
Explain and discuss the categorizing exposure according residence years
Discuss how the exposure categories are handled in comparison of exposed and unexposed and in internal analysis
Keyword(s): Epidemiology, Cancer
Qualified on the content I am responsible for because: I am currently professor in Preventive Medicine at the University of Iceland, and my research and publications include assessment of environmental factors and the possible adverse effects to health, mainly cancer incidence.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.